Antimicrobial Agents and Chemotherapy · 2015 · 36 citations · 27 references
Life SciencesImmunologyPharmacologyHost-pathogen InteractionsInflammationMolecular ImmunologyInflammatory SignalingInnate Immune Signaling PathwaysPathogen RecognitionCytokine Secretion RegulationInflammatory Cytokine SecretionLymphocytic InflammationPathogen-host Interaction TargetingProinflammatory MediatorsSelexStaphylococcal EnterotoxinsToxic Shock Syndrome
Staphylococcal enterotoxin B (SEB) is a major virulence factor for staphylococcal toxic shock syndrome (TSS). SEB activates a large subset of the T lymphocytic population, releasing proinflammatory cytokines. Blocking SEB-initiated toxicity may be an effective strategy for treating TSS. Using a process known as systematic evolution of ligands by exponential enrichment (SELEX), we identified an aptamer that can antagonize SEB with nanomolar binding affinity (Kd = 64 nM). The aptamer antagonist effectively inhibits SEB-mediated proliferation and cytokine secretion in human peripheral blood mononuclear cells. Moreover, a PEGylated aptamer antagonist significantly reduced mortality in a "double-hit" mouse model of SEB-induced TSS, established via sensitization with d-galactosamine followed by SEB challenge. Therefore, our novel aptamer antagonist may offer potential therapeutic efficacy against SEB-mediated TSS.
27
Novel Approach to Specific Growth Factor Inhibition in Vivo
Jürgen Floege, Tammo Ostendorf, Ulf Janssen et al. · American Journal Of Pathology · 1999 · 233 citations · Full text